VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 18.53
-0.28 (-1.49%)
Oct 9, 2026, 11:22 AM HKT
VISEN Pharmaceuticals Revenue
VISEN Pharmaceuticals had revenue of 34.81M CNY in the half year ending June 30, 2026, with 1,133.16% growth. This brings the company's revenue in the last twelve months to 34.06M, up 3,950.06% year-over-year. In the year 2025, VISEN Pharmaceuticals had annual revenue of 136.00K, down -95.10%. That makes VISEN Pharmaceuticals the 39,953rd largest company in the world by revenue and 2,452nd in Hong Kong.
Revenue (ttm)
34.06M CNY
Revenue Growth
+3,950.06%
P/S Ratio
51.73
Revenue / Employee
333.93K CNY
Employees
102
Market Cap
2.03B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 136.00K | -2.64M | -95.10% |
| Dec 31, 2024 | 2.78M | 4.45M | - |
| Dec 31, 2023 | -1.67M | 629.00K | - |
| Dec 31, 2022 | -2.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.